Literature DB >> 19283699

Comparison of 1-D and 2-D LC MS/MS methods for proteomic analysis of human serum.

Martin Gilar1, Petra Olivova, Asish B Chakraborty, Aleksander Jaworski, Scott J Geromanos, John C Gebler.   

Abstract

1-D and 2-D LC methods were utilized for proteome analysis of undepleted human serum. Separation of peptides in 2-D LC was performed either with strong cation exchange (SCX)-RP chromatography or with an RP-RP 2-D LC approach. Peptides were identified by MS/MS using a data-independent acquisition approach. A peptide retention prediction model was used to highlight the potential false-positive peptide identifications. When applying selected data filtration, we identified 52 proteins based on 316 peptides in serum in 1-D LC setup. One hundred and eighty-four proteins/1036 peptides and 142 proteins/905 peptides were identified in RP-RP and SCX-RP 2-D LC, respectively. The performance of both 2-D LC methods for proteomic analysis is critically compared.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19283699     DOI: 10.1002/elps.200800630

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  9 in total

1.  Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry.

Authors:  Catalin E Doneanu; Alex Xenopoulos; Keith Fadgen; Jim Murphy; St John Skilton; Holly Prentice; Martha Stapels; Weibin Chen
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

2.  Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS.

Authors:  Weiguo Sui; Liling Huang; Yong Dai; Jiejing Chen; Qiang Yan; He Huang
Journal:  Clin Exp Med       Date:  2010-04-08       Impact factor: 3.984

3.  Immune Response Resetting in Ongoing Sepsis.

Authors:  Alexandre E Nowill; Márcia C Fornazin; Maria C Spago; Vicente Dorgan Neto; Vitória R P Pinheiro; Simônia S S Alexandre; Edgar O Moraes; Gustavo H M F Souza; Marcos N Eberlin; Lygia A Marques; Eduardo C Meurer; Gilberto C Franchi; Pedro O de Campos-Lima
Journal:  J Immunol       Date:  2019-07-29       Impact factor: 5.422

4.  High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis.

Authors:  Feng Yang; Yufeng Shen; David G Camp; Richard D Smith
Journal:  Expert Rev Proteomics       Date:  2012-04       Impact factor: 3.940

5.  Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells.

Authors:  Yuexi Wang; Feng Yang; Marina A Gritsenko; Yingchun Wang; Therese Clauss; Tao Liu; Yufeng Shen; Matthew E Monroe; Daniel Lopez-Ferrer; Theresa Reno; Ronald J Moore; Richard L Klemke; David G Camp; Richard D Smith
Journal:  Proteomics       Date:  2011-04-18       Impact factor: 3.984

6.  Prometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126.

Authors:  Ying Y Lu; Michael J Sweredoski; David Huss; Rusty Lansford; Sonja Hess; David A Tirrell
Journal:  ACS Chem Biol       Date:  2013-11-25       Impact factor: 5.100

7.  Proteome analysis of subsarcolemmal cardiomyocyte mitochondria: a comparison of different analytical platforms.

Authors:  Francesco Giorgianni; Diwa Koirala; Karl T Weber; Sarka Beranova-Giorgianni
Journal:  Int J Mol Sci       Date:  2014-05-26       Impact factor: 5.923

8.  Proteomic analysis of enterotoxigenic Escherichia coli (ETEC) in neutral and alkaline conditions.

Authors:  Lucia Gonzales-Siles; Roger Karlsson; Diarmuid Kenny; Anders Karlsson; Åsa Sjöling
Journal:  BMC Microbiol       Date:  2017-01-07       Impact factor: 3.605

9.  Correctness of protein identifications of Bacillus subtilis proteome with the indication on potential false positive peptides supported by predictions of their retention times.

Authors:  Katarzyna Macur; Tomasz Baczek; Roman Kaliszan; Caterina Temporini; Federica Corana; Gabriella Massolini; Jolanta Grzenkowicz-Wydra; Michał Obuchowski
Journal:  J Biomed Biotechnol       Date:  2009-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.